Matthew R. Kane Precision Biosciences Inc (DTIL) insider trading activity

Matthew R. Kane is President and CEO of PRECISION BIOSCIENCES INC. Currently has a direct ownership of 2.01 Million shares of DTIL, which is worth approximately $14.6 Million. The most recent transaction as insider was on May 13, 2021, when has been sold 9,675 shares (Common Stock) at a price of $8.96 per share, resulting in proceeds of $86,688. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.01M

0% 3M change

0% 12M change

Total Value Held $14.6 Million

MATTHEW R. KANE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 13 2021	SELL Open market or private sale	$86,688 $8.96 p/Share	9,675 Reduced 0.48%	2,013,597 Common Stock
May 13 2021	BUY Exercise of conversion of derivative security	$861 $0.04 p/Share	21,514 Added 1.05%	2,023,272 Common Stock
May 10 2021	SELL Open market or private sale	$80,404 $8.25 p/Share	9,746 Reduced 0.48%	2,001,758 Common Stock
May 10 2021	BUY Exercise of conversion of derivative security	$861 $0.04 p/Share	21,514 Added 1.06%	2,011,504 Common Stock
May 07 2021	SELL Open market or private sale	$83,489 $8.57 p/Share	9,742 Reduced 0.49%	1,989,990 Common Stock
May 07 2021	BUY Exercise of conversion of derivative security	$861 $0.04 p/Share	21,514 Added 1.06%	1,999,732 Common Stock
Apr 21 2021	BUY Exercise of conversion of derivative security	$15,838 $1.18 p/Share	13,422 Added 0.67%	1,978,218 Common Stock
Apr 12 2021	SELL Open market or private sale	$84,454 $8.67 p/Share	9,741 Reduced 0.49%	1,964,796 Common Stock
Apr 12 2021	BUY Exercise of conversion of derivative security	$861 $0.04 p/Share	21,514 Added 1.08%	1,974,537 Common Stock
Apr 09 2021	SELL Open market or private sale	$86,367 $8.87 p/Share	9,737 Reduced 0.5%	1,953,023 Common Stock
Apr 09 2021	BUY Exercise of conversion of derivative security	$861 $0.04 p/Share	21,514 Added 1.08%	1,962,760 Common Stock
Apr 08 2021	SELL Open market or private sale	$87,624 $9.0 p/Share	9,736 Reduced 0.5%	1,941,246 Common Stock
Apr 08 2021	BUY Exercise of conversion of derivative security	$861 $0.04 p/Share	21,514 Added 1.09%	1,950,982 Common Stock
Mar 12 2021	SELL Open market or private sale	$110,328 $11.36 p/Share	9,712 Reduced 0.5%	1,929,468 Common Stock
Mar 12 2021	BUY Exercise of conversion of derivative security	$861 $0.04 p/Share	21,514 Added 1.1%	1,939,180 Common Stock
Mar 11 2021	SELL Open market or private sale	$110,511 $11.38 p/Share	9,711 Reduced 0.5%	1,917,666 Common Stock
Mar 11 2021	BUY Exercise of conversion of derivative security	$861 $0.04 p/Share	21,514 Added 1.1%	1,927,377 Common Stock
Mar 10 2021	SELL Open market or private sale	$114,481 $11.79 p/Share	9,710 Reduced 0.51%	1,905,863 Common Stock
Mar 10 2021	BUY Exercise of conversion of derivative security	$861 $0.04 p/Share	21,514 Added 1.11%	1,915,573 Common Stock
Feb 18 2021	SELL Open market or private sale	$118,692 $12.23 p/Share	9,705 Reduced 0.51%	1,889,446 Common Stock
Feb 18 2021	BUY Exercise of conversion of derivative security	$861 $0.04 p/Share	21,514 Added 1.12%	1,899,151 Common Stock
Feb 17 2021	SELL Open market or private sale	$119,177 $12.28 p/Share	9,705 Reduced 0.51%	1,877,637 Common Stock
Feb 17 2021	BUY Exercise of conversion of derivative security	$861 $0.04 p/Share	21,514 Added 1.13%	1,887,342 Common Stock
Feb 16 2021	SELL Open market or private sale	$128,970 $13.3 p/Share	9,697 Reduced 0.52%	1,865,828 Common Stock
Feb 16 2021	BUY Exercise of conversion of derivative security	$861 $0.04 p/Share	21,514 Added 1.13%	1,875,525 Common Stock

MRK

Matthew R. Kane

President and CEO

Durham, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DTIL shares.

Notify only if

Value

Insider Trading

Get notified when an Precision Biosciences Inc insider buys or sells DTIL shares.

Notify only if

Operation

Value

Type

News

Receive news related to PRECISION BIOSCIENCES INC

Track Activities on DTIL

Account